In vitro circulation model driven by tissue-engineered dome-shaped cardiac tissue

被引:3
|
作者
Kikuchi, Tetsutaro [1 ]
Matsuura, Katsuhisa [1 ]
Shimizu, Tatsuya [1 ]
机构
[1] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
关键词
cell sheet technology; induced pluripotent stem cell; cardiomyocyte; tissue engineering; organ on a chip; drug screening; CELL-DERIVED CARDIOMYOCYTES; RISK-ASSESSMENT; CONSTRUCTION; FABRICATION; MATURATION; PLATFORM; COLLAGEN;
D O I
10.1088/1758-5090/ac77c1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The heart is an essential organ for animals and humans. With the increased availability of pluripotent stem cells, the use of three-dimensional cardiac tissues consisting of cultured cardiomyocytes in in vitro drug evaluation has been widely studied. Several models have been proposed for the realization of the pump function, which is the original function of the heart. However, there are no models that simulate the human circulatory system using cultured cardiac tissue. This study shows that a dome-shaped cardiac tissue fabricated using the cell sheet stacking technique can achieve a heart-like pump function and circulate culture medium, there by mimicking the human circulatory system. Firstly, human induced pluripotent stem cells were differentiated into autonomously beating cardiomyocytes, and cardiomyocyte cell sheets were created using temperature-responsive culture dishes. A cardiomyocyte sheet and a human dermal fibroblast sheet were stacked using a cell sheet manipulator. This two-layered cell sheet was then inflated to create a dome-shaped cardiac tissue with a base diameter of 8 mm. The volume of the dome-shaped cardiac tissue changed according to the autonomous beating. The stroke volume increased with the culture period and reached 21 +/- 8.9 mu l (n = 6) on day 21. It also responded to beta-stimulant and extracellular calcium concentrations. Internal pressure fluctuations were also recorded under isovolumetric conditions by dedicated culture devices. The peak heights of pulsatile pressure were 0.33 +/- 0.048 mmHg (n = 3) under a basal pressure of 0.5 mmHg on day 19. When the tissue was connected to a flow path that had check valves applied, it drove a directional flow with an average flow rate of approximately 1 mu l s(-1). Furthermore, pressure-volume (P-V) diagrams were created from the simultaneous measurement of changes in pressure and volume under three conditions of fluidic resistance. In conclusion, this cardiac model can potentially be used for biological pumps that drive multi-organ chips and for more accurate in vitro drug evaluation using P-V diagrams.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Tissue-Engineered Heart Valves
    Filova, E.
    Straka, F.
    Mirejovsky, T.
    Masin, J.
    Bacakova, L.
    PHYSIOLOGICAL RESEARCH, 2009, 58 : S141 - S158
  • [32] Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
    Wong, Mei M.
    Hong, Xuechong
    Karamariti, Eirini
    Hu, Yanhua
    Xu, Qingbo
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (97):
  • [33] A tissue-engineered aneurysm model for evaluation of endovascular devices
    Touroo, Jeremy S.
    Williams, Stuart K.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2012, 100A (12) : 3189 - 3196
  • [34] Hydrogel Coating Optimization to Augment Engineered Soft Tissue Mechanics in Tissue-Engineered Blood Vessels
    Wonski, Bryan T.
    Fisher, Bruce
    Lam, Mai T.
    BIOENGINEERING-BASEL, 2023, 10 (07):
  • [35] Functional analysis of the tissue-engineered stomach wall
    Hori, Y
    Nakamura, T
    Kimura, D
    Kaino, K
    Kurokawa, Y
    Satomi, S
    Shimizu, Y
    ARTIFICIAL ORGANS, 2002, 26 (10) : 868 - 872
  • [36] Inflammatory signals in the development of tissue-engineered soft tissue
    Rhodes, Nicholas P.
    BIOMATERIALS, 2007, 28 (34) : 5131 - 5136
  • [37] Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis
    Gartner, Thomas C. L. Bracco
    Crnko, Sandra
    Leiteris, Laurynas
    van Adrichem, Iris
    van Laake, Linda W.
    Bouten, Carlijn V. C.
    Goumans, Marie Jose
    Suyker, Willem J. L.
    Sluijter, Joost P. G.
    Hjortnaes, Jesper
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Tissue-engineered skin substitutes:: from in vitro constructs to in vivo applications
    Auger, FA
    Berthod, F
    Moulin, W
    Pouliot, R
    Germain, L
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 39 : 263 - 275
  • [39] An Optical Method for Evaluation of Geometric Fidelity for Anatomically Shaped Tissue-Engineered Constructs
    Ballyns, Jeffrey J.
    Cohen, Daniel L.
    Malone, Evan
    Maher, Suzanne A.
    Potter, Hollis G.
    Wright, Timothy
    Lipson, Hod
    Bonassar, Lawrence J.
    TISSUE ENGINEERING PART C-METHODS, 2010, 16 (04) : 693 - 703
  • [40] Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model
    Ma, Yifan
    Poisson, Louis
    Sanchez-Schmitz, Guzman
    Pawar, Santosh
    Qu, Chunfeng
    Randolph, Gwendalyn J.
    Warren, William L.
    Mishkin, Eric M.
    Higbee, Russell G.
    IMMUNOLOGY, 2010, 130 (03) : 374 - 387